Dr. Helen J. Ross
Dr. Helen J. Ross is a medical oncologist at the Mayo Clinic Hospital in Phoenix. She specializes in lung cancer and malignant mesothelioma treatment.
Dr. Helen J. Ross
Arizona Mesothelioma Doctor
University of California, Los Angeles, 1984
Cedars-Sinai Medical Center, 1987
University of California, Los Angeles, 1990
Dr. Helen J. Ross is an associate professor at the Mayo Clinic Hospital in Phoenix, Arizona. She is also affiliated with the Mayo Clinic in Scottsdale, Arizona. Dr. Ross has more than 20 years of experience treating patients. She is also actively involved in cancer research. She has helped investigate the efficacy of new treatments and treatment combinations.
Dr. Ross specializes in medical oncology, including the treatment of lung cancer and mesothelioma. She has been involved in clinical trials testing the latest treatments for pleural and peritoneal mesothelioma.
Dr. Ross’s Professional History
Dr. Ross began her medical career in California. She received her medical degree from the University of California, Los Angeles (UCLA). After completing her residency in internal medicine at Cedars-Sinai Medical Center, she returned to UCLA for her fellowship in hematology and oncology.
Dr. Ross currently serves as an associate professor of medicine at the Mayo Clinic College of Medicine and Science. She teaches at the college’s Phoenix/Scottsdale campus. She also treats patients at two Mayo Clinic locations in Arizona.
Dr. Ross has board certifications in internal medicine and medical oncology from the American Board of Internal Medicine. She is also a member of the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR).
During her career, Dr. Ross has actively contributed to research, including investigating treatments for mesothelioma. Some of her research has focused on recurrent mesothelioma. In other words, patients in the study previously underwent treatment and the cancer returned. She has also been involved in research for advanced-stage mesothelioma.
Clinical Interests and Research
Dr. Ross specializes in medical oncology with an interest in thoracic cancers. This means she studies and treats cancers impacting the thoracic cavity or the chest area.
Dr. Ross is actively involved in research. She has co-authored and contributed to more than 90 published articles, book chapters and scientific papers. Much of her research has focused on the efficacy of various cancer treatments. In particular, Dr. Ross has studied treatment for lung cancer, esophageal cancer and mesothelioma.
She has collaborated on clinical trials to investigate the efficacy of radiation therapy and combinations of chemotherapy drugs. She has also contributed to investigations for metastasized and recurrent lung cancer. Her research has been published in various peer-reviewed medical journals, including the Journal of Thoracic Oncology.
Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience. Advances in Radiation Oncology. August 2019;5(3):450-458. doi: 10.1016/j.adro.2019.08.001
Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clinical Lung Cancer. July 2005;7(1):40-6. doi: 10.3816/CLC.2005.n.020
Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program. Journal of Thoracic Oncology. July 2006;1(6):506-12.
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma. Lung Cancer. September 2014;85(3):429-34. doi: 10.1016/j.lungcan.2014.06.008
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program. Lung Cancer. February 2007;55(2):187-94. doi: 10.1016/j.lungcan.2006.09.023
Dr. Ross’s Accolades
Dr. Ross’s clinical excellence and contributions to the medical field have led to various awards throughout her career.
- Exceptional Woman in Medicine (2019, 2020) – Castle Connolly
- Top Oncologist in Phoenix and Scottsdale – International Association of Oncologists
- America’s Top Doctors for Cancer – Castle Connolly